Brady Granier, Chief Operating Officer and Interim Chief Executive Officer of BioCorRx, Inc., Discusses Recent News in a New ...
26 Março 2015 - 9:00AM
SmallCapVoice.com, Inc. (SCV) announced today that a new audio
interview with BioCorRx, Inc. (OTC QB:BICX), developer of the Start
Fresh Program, is now available. The interview can be heard at
http://smallcapvoice.com/blog/3-24-15-smallcapvoice-interview-with-biocorrx-inc-bicx.
COO and interim CEO Brady Granier of BioCorRx, Inc., called in
to SmallCapVoice.com, Inc. to go over the recent news for the
Company. In the interview Mr. Granier discusses the recently
announced execution of a definitive agreement with Myriad Medical
Marketing (MMM), the reinstatement of the letter of understanding
(LOU) to acquire Trinity Rx Solutions and all of its formulas, as
well as new clinic openings so far in 2015.
In the interview Mr. Granier stated, "Things (with Myriad
Medical Marketing (MMM)) are progressing rather quickly. We moved
from the LOI to the definitive agreement in about a month. They are
very eager to get going on this pilot for this new model. It has
all fallen into place rather nicely. With the definitive agreement
now in place all of our interests are aligned."
About SmallCapVoice.com
SmallCapVoice.com is a recognized corporate investor relations
firm, with clients nationwide, known for its ability to help
emerging growth companies build a following among retail and
institutional investors. SmallCapVoice.com utilizes its stock
newsletter to feature its daily stock picks, audio interviews, as
well as its clients' financial news releases. SmallCapVoice.com
also offers individual investors all the tools they need to make
informed decisions about the stocks they are interested in. Tools
like stock charts, stock alerts, and Company Information Sheets can
assist with investing in stocks that are traded on the OTC BB and
Pink Sheets. To learn more about SmallCapVoice.com and their
services, please visit http://www.smallcapvoice.com/services.html
or sign up for our FREE newsletter here
http://www.smallcapvoice.com/newsletter.html.
Visit BioCorRx, Inc.'s investor relations website
www.BICXcorp.com to receive the most up to date company
information.
Click here to view Recent National Television Media on
the BioCorRx YouTube Channel
Click here for company Facebook page for more stories
and media coverage
About BioCorRx, Inc.
BioCorRx, Inc. (R) (BICX) is an addiction treatment and
rehabilitation company offering a unique approach to the treatment
of substance abuse addiction. The Start Fresh Program(R) consists
of two components. The first component of the program consists of
an outpatient implant procedure performed by a licensed physician.
The implant delivers therapeutic levels of the drug Naltrexone, an
opioid antagonist that significantly reduces physical cravings for
alcohol and opioids, into the body. The second component of the
program developed by BioCorRx, Inc. is a one on one coaching
program specifically tailored for the treatment of alcoholism and
other substance abuse addictions. Clinic reports show that the
treatment program can be successful for individuals who complete
the program. For more information on BICX, visit
www.BioCorRx.com
2014 was a pivotal year for BioCorRx, Inc. Clinics using the
Start Fresh Program collectively saw a 402% increase in patients
treated from 2013 to 2014. Over the course of 2015, the company is
continuing the process of developing more new territories to
continue expansion.
Number of clinics at the end of each quarter
-Q1, 2014 -- 5 clinics offering the Start Fresh Program
-Q2, 2014 -- 6 clinics offering the Start Fresh Program
-Q3, 2014 -- 6 clinics offering the Start Fresh Program
-Q4, 2014 -- 10 clinics offering the Start Fresh Program
-Q1, 2015 to date - 13 clinics offering the Start Fresh
Program
Safe Harbor Statement
The information in this release includes forward-looking
statements. These forward-looking statements generally are
identified by the words "believe," "project," "estimate," "become,"
"plan," "will," and similar expressions. These forward-looking
statements involve known and unknown risks as well as
uncertainties. Although the Company believes that its expectations
are based on reasonable assumptions, the actual results that the
Company may achieve may differ materially from any forward-looking
statements, which reflect the opinions of the management of the
Company only as of the date hereof.
CONTACT: Investor Relations
SmallCapVoice.com, Inc.
512-267-2430
info@smallcapvoice.com
BioCorRx (QB) (USOTC:BICX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
BioCorRx (QB) (USOTC:BICX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024